Kaplan-Meier plots of recurrence free survival in breast cancer patients from the validation set predicted by the Tc/ClassII immune signature score in conjunction with the PCNA⁺ TAMs surrogate score.

<p>(A) Kaplan-Meier curves for RFS comparing patients with a high PCNA⁺ TAMs surrogate score and a low Tc/ClassII score (n=59) to all other patients (n=366). (B) Kaplan-Meier curves for RFS in hormone receptor negative cases only; high PCNA⁺ TAMs surrogate score and a low Tc/ClassII score (n=30) to all other HR negative cases (n=123). Differences between groups were assessed using the log rank test, with p values indicated in each plot.